LCN2 and acute kidney injury: For example, recent studies have suggested that urinary biomarkers such as kidney injury molecule-1 (KIM-1), N-acetyl-(d)-glucosaminidase (NAG), and neutrophil gelatinase-associated lipocalin (NGAL) are helpful in diagnosing AKI and in predicting mortality in various clinical settings [13–15].